BR9906581A - Processo para administração de taxano encapsulado em lipossomos - Google Patents
Processo para administração de taxano encapsulado em lipossomosInfo
- Publication number
- BR9906581A BR9906581A BR9906581-9A BR9906581A BR9906581A BR 9906581 A BR9906581 A BR 9906581A BR 9906581 A BR9906581 A BR 9906581A BR 9906581 A BR9906581 A BR 9906581A
- Authority
- BR
- Brazil
- Prior art keywords
- liposomes
- encapsulated
- taxane
- administration
- taxane encapsulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
<B>PROCESSO PARA ADMINISTRAçãO DE TAXANO ENCAPSULADO EM LIPOSSOMOS<D> é provido taxano encapsulado em lipossomos ou um derivado antineoplástico ou mistura do mesmo, que é empregado para efetuar um processo terapeuticamente aperfeiçoado para o tratamento do câncer. O paclitaxel encapsulado em lipossomos permite a administração a um paciente, especificamente um paciente humano, em menos de uma hora, sem toxicidade substancial.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/108,509 US6146659A (en) | 1998-07-01 | 1998-07-01 | Method of administering liposomal encapsulated taxane |
PCT/US1999/014986 WO2000001366A1 (en) | 1998-07-01 | 1999-06-29 | A method of administering liposomal encapsulated taxane |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9906581A true BR9906581A (pt) | 2000-09-26 |
Family
ID=22322617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9906581-9A BR9906581A (pt) | 1998-07-01 | 1999-06-29 | Processo para administração de taxano encapsulado em lipossomos |
Country Status (17)
Country | Link |
---|---|
US (1) | US6146659A (pt) |
EP (1) | EP1009384A4 (pt) |
JP (2) | JP2001524990A (pt) |
KR (1) | KR20010023522A (pt) |
CN (1) | CN1275076A (pt) |
AU (1) | AU730599B2 (pt) |
BR (1) | BR9906581A (pt) |
CA (1) | CA2301057C (pt) |
EA (1) | EA003678B1 (pt) |
HU (1) | HUP0004583A3 (pt) |
IL (1) | IL134747A0 (pt) |
NO (1) | NO20001012L (pt) |
NZ (1) | NZ524490A (pt) |
PL (1) | PL338951A1 (pt) |
SK (1) | SK4642000A3 (pt) |
TR (1) | TR200000576T1 (pt) |
WO (1) | WO2000001366A1 (pt) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030087954A1 (en) * | 1997-01-07 | 2003-05-08 | Sonus Pharmaceuticals, Inc. | Method of treating bladder carcinoma using a Taxane/Tocopherol formulation |
US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US7112338B2 (en) * | 1997-03-12 | 2006-09-26 | The Regents Of The University Of California | Cationic liposome delivery of taxanes to angiogenic blood vessels |
US7262173B2 (en) * | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
US7314637B1 (en) * | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6461637B1 (en) * | 2000-09-01 | 2002-10-08 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US7915238B2 (en) * | 1999-02-01 | 2011-03-29 | Eisai R & D Management Co., Ltd. | Immunomodulatory compounds and methods of use thereof |
US20040006242A1 (en) * | 1999-02-01 | 2004-01-08 | Hawkins Lynn D. | Immunomodulatory compounds and method of use thereof |
US6835721B2 (en) * | 1999-02-01 | 2004-12-28 | Eisai Co., Ltd. | Immunomodulatory compounds and methods of use thereof |
USRE43914E1 (en) * | 1999-06-09 | 2013-01-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Method for detecting syphilis using synthetic antigens |
CZ2002850A3 (cs) * | 1999-09-09 | 2003-04-16 | The Regents Of The University Of California | Kationtový liposom a použití kationtového liposomového prostředku |
AR030188A1 (es) * | 2000-02-02 | 2003-08-13 | Univ Florida State Res Found | Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos |
EP1259225B1 (en) * | 2000-02-04 | 2006-10-04 | Lipoxen Technologies Limited | Process of dehydration/rehydration for making liposomes |
US20030129223A1 (en) * | 2000-10-11 | 2003-07-10 | Targesome, Inc. | Targeted multivalent macromolecules |
US20030133972A1 (en) * | 2000-10-11 | 2003-07-17 | Targesome, Inc. | Targeted multivalent macromolecules |
BR0115260A (pt) | 2000-11-09 | 2005-08-16 | Neopharm Inc | Complexos de sn-38 com lipìdeos e seus usos no tratamento de doenças |
US20020073441A1 (en) | 2000-12-13 | 2002-06-13 | Ross Brian D. | Compositions and methods for detecting proteolytic activity |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
CA2354486A1 (en) * | 2001-07-31 | 2003-01-31 | Florida State University Research Foundation, Inc. | C7 ester substituted taxanes |
WO2003018018A2 (en) * | 2001-08-24 | 2003-03-06 | Neopharm, Inc. | Vinorelbine compositions and methods of use |
DE10154464B4 (de) * | 2001-11-08 | 2005-10-20 | Max Delbrueck Centrum | Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol |
EP1448237A1 (en) * | 2001-11-09 | 2004-08-25 | Neopharm, Inc. | Selective treatment of il-13 expressing tumors |
US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
US20030180348A1 (en) * | 2002-03-22 | 2003-09-25 | Levinson R. Saul | Transcellular drug delivery system |
US7138512B2 (en) * | 2002-04-10 | 2006-11-21 | Georgetown University | Gene SHINC-2 and diagnostic and therapeutic uses thereof |
AU2003234670B2 (en) | 2002-05-24 | 2010-06-10 | Angiotech International Ag | Compositions and methods for coating medical implants |
WO2003102011A1 (en) * | 2002-05-29 | 2003-12-11 | Neopharm, Inc. | Method for determining oligonucleotide concentration |
DK1521572T3 (da) * | 2002-07-15 | 2009-05-04 | Alcon Inc | Biologisk nedbrydelig film til indförsel af öjenlægemiddel |
KR100533458B1 (ko) | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | 파클리탁셀의 가용화용 조성물 및 그의 제조 방법 |
WO2004017944A1 (en) * | 2002-08-23 | 2004-03-04 | Neopharm, Inc. | Liposomal gemcitabine compositions for better drug delivery |
WO2004069224A2 (en) * | 2003-02-03 | 2004-08-19 | Neopharm, Inc. | Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
EA200501285A1 (ru) * | 2003-02-11 | 2006-02-24 | Неофарм, Инк. | Способ получения липосомальных препаратов |
WO2004087758A2 (en) * | 2003-03-26 | 2004-10-14 | Neopharm, Inc. | Il 13 receptor alpha 2 antibody and methods of use |
US20060165744A1 (en) * | 2003-05-22 | 2006-07-27 | Neopharm, Inc | Combination liposomal formulations |
US20060078560A1 (en) * | 2003-06-23 | 2006-04-13 | Neopharm, Inc. | Method of inducing apoptosis and inhibiting cardiolipin synthesis |
US20080063699A1 (en) * | 2003-10-15 | 2008-03-13 | Michael Teifel | Method of Administering Cationic Liposomes Comprising an Active Drug |
TW200540164A (en) | 2004-03-05 | 2005-12-16 | Univ Florida State Res Found | C7 lactyloxy-substituted taxanes |
US8022279B2 (en) * | 2004-04-22 | 2011-09-20 | Celator Pharmaceuticals, Inc. | Liposomal formulations of anthracycline agents and cytidine analogs |
JP4433918B2 (ja) * | 2004-07-15 | 2010-03-17 | コニカミノルタエムジー株式会社 | 画像形成方法 |
JP2008518925A (ja) * | 2004-10-29 | 2008-06-05 | ネオファーム、インコーポレイティッド | リポソーム製剤の製造プロセス |
US8178129B2 (en) | 2004-11-02 | 2012-05-15 | Tel-Aviv University Future Technology Development L.P. | Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy |
KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
US20070292418A1 (en) * | 2005-04-26 | 2007-12-20 | Eisai Co., Ltd. | Compositions and methods for immunotherapy |
WO2006116423A2 (en) | 2005-04-26 | 2006-11-02 | Eisai Co., Ltd | Compositions and methods for cancer immunotherapy |
US9233094B2 (en) | 2005-05-04 | 2016-01-12 | Medigene Ag | Method of administering a cationic liposomal preparation |
MX2008011978A (es) | 2006-03-22 | 2009-04-22 | Medigene Ag | Tratamiento del cancer de seno negativo al triple receptor. |
CA2648939C (en) | 2006-04-20 | 2014-07-08 | Amgen Inc. | Stable emulsion formulations |
US9637515B2 (en) | 2006-11-06 | 2017-05-02 | Jina Pharmaceuticals, Inc. | Guggulphospholipid methods and compositions |
GB0905348D0 (en) * | 2009-03-27 | 2009-05-13 | Ucl Business Plc | Carrier |
US20110070294A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods for the Administration of Drugs Using Liposomes |
US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
CA2781529C (en) | 2009-09-23 | 2017-10-24 | Indu Javeri | Methods for the preparation of liposomes comprising docetaxel |
PL226015B1 (pl) * | 2011-03-03 | 2017-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna |
US10188728B2 (en) | 2012-12-12 | 2019-01-29 | Temple University—Of the Commonwealth System of Higher Education | Compositions and methods for treatment of cancer |
US20160128971A1 (en) * | 2013-04-05 | 2016-05-12 | Vuong Trieu | Nanoparticle Compositions |
SG11201601311VA (en) * | 2013-09-13 | 2016-03-30 | Arbor Therapeutics Llc | Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861580A (en) * | 1985-10-15 | 1989-08-29 | The Liposome Company, Inc. | Composition using salt form of organic acid derivative of alpha-tocopheral |
US4812314A (en) * | 1986-02-24 | 1989-03-14 | Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization | Lipid replacement therapy |
US4927571A (en) * | 1987-05-18 | 1990-05-22 | Liposome Technology, Inc. | Preparation of injectable doxorubicin/liposome suspension |
ES2148223T3 (es) * | 1992-03-23 | 2000-10-16 | Univ Georgetown | Taxol encapsulado en liposomas y metodo para su uso. |
AU6833994A (en) * | 1993-05-17 | 1994-12-12 | Liposome Company, Inc., The | Incorporation of taxol into liposomes and gels |
JPH06329533A (ja) * | 1993-05-20 | 1994-11-29 | Kyowa Hakko Kogyo Co Ltd | リポソーム製剤の製造法 |
US5415869A (en) * | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
DE4447770C2 (de) * | 1994-08-20 | 2002-12-19 | Max Delbrueck Centrum | Verfahren zur Herstellung von liposomal verkapseltem Taxol |
EP0792143B1 (en) * | 1994-11-18 | 2002-09-04 | Aphios Corporation | Methods for making liposomes containing hydrophobic drugs |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
HU226325B1 (en) * | 1995-09-12 | 2008-08-28 | Cephalon Ltd | Hydrolysis-promoting hydrophobic taxane derivatives, medicaments comprising them and the use of medicaments |
US5756537A (en) * | 1996-11-08 | 1998-05-26 | Parkash S. Gill, M.D., Inc. | Regime for paclitaxel in Kaposi's sarcoma patients |
-
1998
- 1998-07-01 US US09/108,509 patent/US6146659A/en not_active Expired - Lifetime
-
1999
- 1999-06-29 BR BR9906581-9A patent/BR9906581A/pt not_active Application Discontinuation
- 1999-06-29 PL PL99338951A patent/PL338951A1/xx unknown
- 1999-06-29 KR KR1020007002168A patent/KR20010023522A/ko not_active Application Discontinuation
- 1999-06-29 EA EA200000282A patent/EA003678B1/ru not_active IP Right Cessation
- 1999-06-29 IL IL13474799A patent/IL134747A0/xx unknown
- 1999-06-29 EP EP99935394A patent/EP1009384A4/en not_active Withdrawn
- 1999-06-29 WO PCT/US1999/014986 patent/WO2000001366A1/en not_active Application Discontinuation
- 1999-06-29 NZ NZ524490A patent/NZ524490A/en unknown
- 1999-06-29 TR TR2000/00576T patent/TR200000576T1/xx unknown
- 1999-06-29 CA CA002301057A patent/CA2301057C/en not_active Expired - Fee Related
- 1999-06-29 AU AU50880/99A patent/AU730599B2/en not_active Ceased
- 1999-06-29 JP JP55462599A patent/JP2001524990A/ja active Pending
- 1999-06-29 SK SK464-2000A patent/SK4642000A3/sk unknown
- 1999-06-29 CN CN99801424A patent/CN1275076A/zh active Pending
- 1999-06-29 HU HU0004583A patent/HUP0004583A3/hu unknown
-
2000
- 2000-02-29 NO NO20001012A patent/NO20001012L/no not_active Application Discontinuation
-
2003
- 2003-07-16 JP JP2003197879A patent/JP2004059590A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1009384A1 (en) | 2000-06-21 |
HUP0004583A3 (en) | 2002-04-29 |
CN1275076A (zh) | 2000-11-29 |
CA2301057A1 (en) | 2000-01-13 |
NO20001012D0 (no) | 2000-02-29 |
CA2301057C (en) | 2009-03-10 |
EP1009384A4 (en) | 2004-11-17 |
PL338951A1 (en) | 2000-12-04 |
AU5088099A (en) | 2000-01-24 |
TR200000576T1 (tr) | 2000-11-21 |
KR20010023522A (ko) | 2001-03-26 |
EA200000282A1 (ru) | 2000-10-30 |
US6146659A (en) | 2000-11-14 |
WO2000001366A1 (en) | 2000-01-13 |
JP2001524990A (ja) | 2001-12-04 |
SK4642000A3 (en) | 2000-11-07 |
JP2004059590A (ja) | 2004-02-26 |
AU730599B2 (en) | 2001-03-08 |
NO20001012L (no) | 2000-03-15 |
IL134747A0 (en) | 2001-04-30 |
EA003678B1 (ru) | 2003-08-28 |
NZ524490A (en) | 2005-04-29 |
HUP0004583A2 (hu) | 2001-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9906581A (pt) | Processo para administração de taxano encapsulado em lipossomos | |
BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
PA8479201A1 (es) | Derivados del acido hidroxi-pipecolato hidroxamico | |
BR0115162A (pt) | Tratamentos antitumorais eficazes | |
BR0009647A (pt) | Docetaxel em combinação com rhumab her2 para o tratamento de cânceres | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
HUP0002521A2 (hu) | A paclitaxel ónium sói, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények | |
BRPI0407897A (pt) | derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios | |
MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
HK1102991A1 (en) | Pharmaceutical formulation of decitabine | |
AR025444A1 (es) | Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
WO2002058694A3 (en) | Method of treating hematologic tumors and cancers using beta lapachone | |
NO20040096L (no) | Taxol-forbedringsforbindelser | |
BR0312845A (pt) | Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
AR034223A1 (es) | Novedosa indicacion terapeutica de azitromicina para el tratamiento de enfermedades inflamatorias no infecciosas | |
ES2191449T3 (es) | Derivados de ciclopentabenzofurano y su uso. | |
DE60222383D1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
ATE233745T1 (de) | Arzneistoffe | |
BR0214564A (pt) | Processos de tratamento de câncer utilizando um inibidor da fpt e agentes antineoplásicos | |
BR0114856A (pt) | Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer | |
BR0004813A (pt) | Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori | |
SE0004827D0 (sv) | Therapeutic compounds | |
MX9305152A (es) | Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |